Follow-The-Filings

ASND position history

The shares of Ascendis Pharma A/S (ASND) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.

Equity · SPONSORED ADR

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q2 · 2,719 shares · $469K · <0.01% of portfolio · New
  2. 2025 Q3 · 2,766 shares · $550K · <0.01% of portfolio · Add +1.7%
  3. 2025 Q4 · 1,211 shares · $258K · <0.01% of portfolio · Reduce −56.2%
  4. 2026 Q1 · 1,812 shares · $414K · <0.01% of portfolio · Add +49.6%
  5. 2026 Q2 · not held · Exit
Holdings date Value % of holdings Shares Filing date All 13F holders